Terns Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Terns Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Terns Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Terns Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $34M | 635k | 52.72 |
| 2025-12-31 | $39M | 974k | 40.40 |
| 2025-09-30 | $708k | 94k | 7.52 |
| 2025-06-30 | $297k | 80k | 3.73 |
| 2025-03-31 | $210k | 76k | 2.76 |
| 2024-12-31 | $8.3M | 1.5M | 5.54 |
| 2024-09-30 | $12M | 1.5M | 8.34 |
| 2024-06-30 | $182k | 27k | 6.82 |
| 2024-03-31 | $136k | 21k | 6.57 |
| 2023-12-31 | $120k | 18k | 6.51 |
| 2023-09-30 | $90k | 18k | 5.06 |
| 2023-06-30 | $149k | 17k | 8.77 |